DXCM (DexCom) Days Payable : 79.34 (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is DexCom Days Payable?

DexCom's average Accounts Payable for the three months ended in Mar. 2025 was $389 Mil. DexCom's Cost of Goods Sold for the three months ended in Mar. 2025 was $447 Mil. Hence, DexCom's Days Payable for the three months ended in Mar. 2025 was 79.34.

The historical rank and industry rank for DexCom's Days Payable or its related term are showing as below:

DXCM' s Days Payable Range Over the Past 10 Years
Min: 42.67 Med: 70.59 Max: 83.81
Current: 72.91

During the past 13 years, DexCom's highest Days Payable was 83.81. The lowest was 42.67. And the median was 70.59.

DXCM's Days Payable is ranked better than
52.73% of 787 companies
in the Medical Devices & Instruments industry
Industry Median: 68.67 vs DXCM: 72.91

DexCom's Days Payable increased from Mar. 2024 (69.38) to Mar. 2025 (79.34). It may suggest that DexCom delayed paying its suppliers.

DexCom Days Payable Historical Data

The historical data trend for DexCom's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Days Payable Chart

DexCom Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

74.96

83.81

75.95

70.39

71.14

DexCom Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Payable	Get a 7-Day Free Trial															69.38	69.68	72.20	66.98	79.34

Competitive Comparison of DexCom's Days Payable

For the Medical Devices subindustry, DexCom's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexCom's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Days Payable distribution charts can be found below:

* The bar in red indicates where DexCom's Days Payable falls into.

Save Embed

;

Save Embed

;

DexCom Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

DexCom's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (276.4	+	345.3)	/	2 )	/	1594.8	*	365
=	310.85					/	1594.8	*	365
=	71.14

DexCom's Days Payable for the quarter that ended in Mar. 2025 is calculated as:

	Days Payable (Q: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2024 )	+	Accounts Payable (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (345.3	+	432)	/	2 )	/	447	*	365 / 4
=	388.65					/	447	*	365 / 4
=	79.34

DexCom Days Payable Related Terms

Thank you for viewing the detailed overview of DexCom's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

DexCom Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (NAS:DXCM) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

DXCM:Mexico 0A4M:UK DC4:Germany DC4:Germany DC4:Germany DC4:Germany D1EX34:Brazil DXCM:Austria

Address

6340 Sequence Drive, San Diego, CA, USA, 92121

Website

https://www.dexcom.com

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Executives

Sadie Stern	officer: Chief Human Resources Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Micheal Jon Brown	officer: EVP, Chief Legal Officer	6340 SEQUENCE DR, SAN DIEGO CA 92121
Bridgette P Heller	director	TECH DATA CORPORATION, 5350 TECH DATA DRIVE, CLEARWATER FL 33760
Jacob Steven Leach	officer: SVP, Research & Development	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Jereme M Sylvain	officer: SVP, Finance & CAO	6340 SEQUENCE DRIVE, SAN DIEGO X1 92121
Kevin R Sayer	director
Matthew Vincent Dolan	officer: *	6340 SEQUENCE DR, SAN DIEGO CA 92121
Mark G Foletta	director	AMYLIN PHARMACEUTICALS INC, 9360 TOWNE CENTRE DR, SAN DIEGO CA 92121
Teri L Lawver	officer: EVP Chief Commercial Officer	C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Steven R Altman	director
Nicholas Augustinos	director	754 GRAND VIEW AVENUE, SAN FRANCISCO CA 94114
Steven Robert Pacelli	officer: Vice President Legal Affairs	5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Girish Naganathan	officer: EVP Chief Technology Officer	C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Barry J. Regan	officer: EVP Operations	1023 CHERRY ROAD, MEMPHIS TN 38117
Rimma Driscoll	director	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054